US Patent 11298362 Combination therapy with Notch and CDK4/6 inhibitors for the treatment of cancer
Patent 11298362 was granted and assigned to Eli Lilly and Company on April, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11298362 Combination therapy with Notch and CDK4/6 inhibitors for the treatment of cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.